Red Pharmacy

Posted by
Brett EmisonJanuary 11, 2012 11:35 AM
0 CommentsPrint ArticleSubscribe

we wrote final week about a potential allotment of thousands of Yaz, Yasmin, and Ocella lawsuits following Judge David Herndon’s sequence requiring a parties to intercede and suspending bellwether trials usually 9 days before a initial hearing was set to begin.

On Monday, Judge Herndon simplified his order. Judge Herndon done certain that now tentative case-specific and general find will continue as such find will yield information that is vicious to a gratefulness of these cases for settlement.

The Court also reiterated a requirement of good faith in a intervention and negotiating process. If a Court determines that a parties negotiated in good faith, though were legitimately incompetent to strech a settlement, afterwards a Court will resume a bellwether routine with a initial hearing to start on April 30, 2012. However, if a Court determines that one of a parties has not negotiated in good faith, it will desert a bellwether routine and simply remand a particular cases for hearing in their correct venue districts. The impassioned cost of litigating thousands of particular cases puts increasing vigour on Bayer – who made Yaz – to intercede and negotiate Yaz settlements in good faith.

[Read Case Management Order No. 54]

Yesterday, a Court stayed some of a deadlines in a Order that are really tighten in time and that competence impede a intervention and allotment traffic process. However, Judge Herndon kept a Apr 30, 2012 bellwether hearing date. In progressing a Apr 30, 2012 bellwether hearing date, Judge Herndon also ensured there would not be a estimable check if a intervention and allotment negotiations are not successful.

[Read Minute Order Staying Discovery and Bellwether Deadlines for 60 Days]

Why Are Yaz, Yasmin, Ocella So Dangerous?

Popular birth control pills, Yaz, Yasmin and Ocella, have been linked to critical and potentially lethal side effects. Yaz side effects and health problems impact women of all ages, including teenagers and immature women.

Yaz, Yasmin and Ocella have been related to critical side effects, such as heart attack, stroke, pulmonary embolism (PE), low capillary thrombosis (DVT),gallbladder disease and remarkable cardiac death.

Despite these critical side effects, Bayer marketed these drugs to immature women not usually as a contraceptive, though to soothe symptoms of critical PMS and as an acne fighter.

The FDA reprimanded Bayer [in 2009] for overstating a advantages and downplaying a risks of Yaz in radio advertisements. The aphorism for Yaz was “beyond birth control.”

Bayer marketed Yaz to women in their 20s. Commercials cultivated a hip, childish picture set to stone music, and advertised Yaz as a diagnosis for acne and premenstrual syndrome (PMS).

The FDA called Bayer’s advertisements “misleading” and reprimanded Bayer in a series of central FDA letters. Bayer’s control was so gross that a FDA systematic Bayer to run a $20 million “corrective” ad campaign.

You can review a central FDA warning letters here:

• 2003 FDA Yaz Warning Letter
• 2008 FDA Yaz Warning Letter
• 2009 FDA Yaz Warning Letter

The dangerous law-breaker in Yaz, Yasmin, and Ocella is drospirenone, a fake (artificial) hormone that has been related to blood clotting disorders and gallbladder disease. Yaz, Yasmin, Ocella and their generic-brand counterparts (including Beyaz and Vestura) mix estrogen with a fake progestin Drospirenone. No other verbal preventive (or birth control pill) contains Drospirenone.

Drospirenone has been related to critical side effects including blood clots, heart attack, stroke, pulmonary embolism, low capillary thrombosis (DVT), and even gallbladder disease.

In a recently expelled FDA saved study that compared several opposite forms of verbal contraceptives, those that enclose drospirenone were shown to boost blood clot risks by 75%.

Blood clotting is a normal corporeal function. This duty routinely stops blood upsurge from cuts and creates scabs to stop bleeding. This duty repairs repairs to a skin and other physique tissues. However, a chemical combinations in Vestura, Yaz, Yasmin and Ocella can means aberrant blood clotting. This formula in blood clotting when it is nonessential and inside a blood vessel, capillary or artery.

These aberrant blood clots can mangle divided from a blood vessel on that they formed. When these clots mangle divided they transport by a blood tide and can form a blockage or turn lodged inside a heart itself. This blockage can starve a upsurge of blood and means a heart attack.

If a blood clot lodges in a mind (rather than a heart), it can outcome in a stroke.

If a blood clot lodges in a pulmonary artery that reserve blood to a lungs, it can outcome in a pulmonary embolism (or PE).

Despite these documented risks, Bayer continues to marketplace and sell Yaz, Yasmin, and Ocella to millions of immature women. In 2010 alone, Yaz brought in increase of $1.6 billion. Bayer set aside 50 million Euro for expected Yaz lawsuit invulnerability costs.

It’s time for Bayer to stop putting increase over safety. It’s time for Bayer to accept shortcoming for a dangerous birth control pills that have busted a lives of thousands of immature women. It’s time for Bayer to finish this lawsuit by intervention and lift this dangerous drug from a market.

[More on Yaz Side Effects, Risks, and Yaz Lawsuits]

(c) Copyright 2012 Brett A. Emison

Follow @BrettEmison on Twitter.

Tags: Yaz, Yasmin, Ocella, Lawsuit, Litigation, Settlement, MDL, Mediation, Side Effects, Blood Clot, Heart Attack, Stroke, DVT, PE, Gallbladder, FDA, Beyaz, Safyral, Vestura

Incoming search terms:

• 966 oil @yahoo com sa 2012
• online bahamas male@yahoo com @hotmail com seeking for female in 2012

Have we detected agave nectar on your grocery store shelves?

If you’re perplexing to cut out synthetic sweeteners and equivocate white sugar, agave is done from a Mexican agave plant – sweeter than sugarine though with a low Glycemic Index of 32, definition that it causes reduction of a blood sugarine spike.

Agave nectar is best kept during room temperature, and is good for during slightest a year once opened. Gluten and allergen-free, use 1/3 crater for each 1 crater of sugarine in a recipe. And it’s tasty in iced tea.

Put down a cookies, step divided from a fridge.

It’s tough to go cold turkey in a New Year, so batch adult with satisfying, sustaining eats, like this zingy lemony hummus that creates celery and carrot sticks some-more of a meal.

Make this tawny hummus from blemish with canned garbanzo beans (also called chickpeas), a firm, chewy, somewhat honeyed bean.

This drop is reduction costly than a store-bought kind, and full of protein, low in unsaturated fat and high in fiber. And we can chuck it together in about 10 minutes.

Make-Your-Own Lemony Hummus

Make 2 cups

15-ounce can garbanzo beans, emptied and rinsed

3 tablespoons water

4 tablespoons lemon juice

1 clove garlic, peeled

2 teaspoons belligerent cumin

2 teaspoons coriander

1 teaspoon paprika, and some-more for garnish

1 tablespoon olive oil, and some-more for drizzling

1/2 teaspoon counterfeit salt

Combine all mixture in a food processor or blender until smooth, scraping sides of bowl.

Transfer to a play and drizzle with olive oil and shower with paprika. Cover and cool adult to a week.

Vanderbilt interventional cardiologists and surgeons successfully achieved a state’s initial transcatheter aortic heart valve-replacement (TAVR) with a new FDA-approved percutaneous synthetic valve.

Joseph Fredi, M.D., David Zhao, M.D., and John Byrne, M.D., perform a new transcatheter aortic valve-replacement procession in Vanderbilt’s hybrid OR. (photo by Joe Howell)

On Jan. 5, Vanderbilt physicians used a Edwards SAPIEN Transcatheter Heart Valve, done of cow tissue, on dual patients. Approved in Nov 2011, this is a initial U.S. blurb capitulation for a transcatheter device enabling aortic valve deputy but a need for open-heart surgery.

Nearly 200,000 people any year are diagnosed with aortic stenosis, a squeezing of a categorical valve permitting blood to leave a heart. Seventy-five percent of those diagnosed are deemed high risk or incompetent for open-heart medicine – a customary therapy.

Helen Williams, 80, of White Bluff, Tenn., was VUMC’s initial target of a novel valve deputy technique. The accessibility of a new valve saved her life when she was deemed too diseased to hoop customary open heart surgery.

“There are no other options for this organisation of patients,” pronounced David Zhao, M.D., executive of a Cardiovascular Catheterization Lab and Interventional Cardiology. “With this new procedure, there will be an comprehensive 20 percent rebate in mortality. This is transformational record and can potentially save thousands of lives.”

Williams, who underwent a procession on Thursday, pronounced she “feared her life would be shortened” when she schooled she would need heart surgery. Instead, she went home within 48 hours of receiving her new valve and is recuperating nicely.

The VHVI team, comprised of Zhao, John G. Byrne, M.D., Joseph Fredi, M.D., Mark Robbins, M.D., Marshall Crenshaw, M.D., and Steve Ball, M.D., began regulating transcatheter aortic valves in adult patients in Jul 2011 when it embarked on a clinical hearing of Medtronic’s CoreValve. Vanderbilt is one of a few medical centers in a nation to offer both a CoreValve and a SAPIEN valve, Zhao said.

The multidisciplinary group also includes Lisa Mendes, M.D., Mike Baker, M.D., a group of cardiac anesthesiologists, and teams from a cath lab and handling rooms.

Zhao anticipates behaving several hundred deputy procedures a year regulating a newest record from Edwards SAPIEN.

The valve is done with cow pericardial hankie and a balloon expandable immaculate steel frame. Using transcatheter aortic valve implantation, an synthetic aortic heart valve is trustworthy to a handle support and guided by catheter by a groin to a heart.

Once in place, a handle support expands, permitting a new aortic valve to open and start to siphon blood.

Compared to a 4 to 6 hours customary in open-heart surgeries, this procession calls for a smaller rent and takes about 90 mins to complete.

Byrne, William S. Stoney Professor and Chairman of a Department of Cardiac Surgery, pronounced a non-surgical valve deputy technique will turn a customary therapy in a subsequent 3 to 5 years.

“Vanderbilt is a informal personality in transcatheter aortic valve therapy,” he said.

Byrne attributes a fast success of a TAVR module to a teamwork, common prophesy and goals between Vanderbilt’s cardiologists and cardiac surgeons, determined with a opening of a hybrid OR in 2005, that has eased a approach for a TAVR program.

“Few centers are means to govern like Vanderbilt since they humour from a normal attrition that has prolonged existed between these dual groups,” Byrne said.

Media Inquiries:
Kathy Whitney
Information Officer
News and Communications
Phone: 615-322-4747